Stock Ratings / Technology / ZEPP / earnings

OSS (47) SCKT (40) XNDU (49) OMCL (61) ⌘ Pro Terminal →

Zepp Health Corporation each representing sixteen (Class A) (ZEPP) Next Earnings Date & Expected ±12.5% Move

Q: Is ZEPP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.25 (-3.85% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #624 in composite RQD confidence.

Q: How does ZEPP compare to OSS and SCKT in the Technology sector?

Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D grade (47/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for ZEPP?

Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is ZEPP trading relative to its 50-day, 200-day, and 52-week technical levels?

ZEPP last traded at $2.25 (-3.85% on volume of 68,747 shares), positioning the stock -43.18% below its 50-day simple moving average ($3.96) and -77.88% below its 200-day simple moving average ($10.17). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.2% percentile with a 14-day RSI of 11.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.97 to $2.53).

Q: When is ZEPP's next earnings date?

Based on SEC filing cadence, Zepp Health Corporation each representing sixteen (Class A) (ZEPP)'s next quarterly reporting window is estimated around Dec 30, 2026.

Q: How much is ZEPP stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for ZEPP, spanning a range between $1.97 and $2.53.

$2.25 -3.85% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.23

Zepp Health Corporation each representing sixteen (Class A) (ZEPP) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $33.0M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.23 (-0.88%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-10.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ZEPP)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (35/100 Composite)

🔍 WHY ZEPP SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (37% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 12 (OVERSOLD (<32))

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (23% of score)

Altman Z-Score 0.33 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9

▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)

Capital intensity & 0% operating margin leave 16 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$3.72-18.8% Next Q

Q2 (-2Q)

Grade D$3.02-13.6% Next Q

Q3 (-1Q)

Grade E$2.61-13.8% Next Q

Current

Grade D-$2.25-8.5% Hist 90D α

Trajectory: D (43) → D- (35)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ZEPP Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ZEPP currently carries a cautious 35/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.96) and Max Pain ($2.36) forces dealer call-delta covering toward $44.47.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ZEPP• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ZEPP Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 35%NO 65%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.28 Expected Swing

MODEL EARNINGS SETUP GAUGE

ZEPP Quantitative Pre-Earnings Setup: 35/100

Trailing EPS: $4.25 • YoY Revenue Growth: 41.8%

Model Bullish Setup (35/100)Model Risk Weight (65/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$258.9M	-$40.1M	-$26.2M	38.3%
FY 2024	2024-12-31	$182.6M	-$75.7M	-$25.8M	38.5%
FY 2023	2023-12-31	$352.9M	-$31.0M	$42.6M	38.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ZEPP)

✓Walkthrough of ZEPP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ZEPP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -87.12%🛡️ HOLDING TREND SUPPORT

2026-10-30O $2.16H $2.25L $2.15C $2.25VOL 112.6K

RES: $6.64SUP: $1.76SMA50: $3.96SMA200: $10.17

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ZEPP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ZEPP Butterfly Map → + Track ZEPP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +41.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ZEPP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ZEPP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ZEPP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ZEPP)

Technology Rank #624 of 714 ⚔️ OSS vs ZEPP Full Matrix →

1. Head-to-Head Technology Peer Comparison (ZEPP vs. OSS, SCKT, XNDU, OMCL)

Industry: Computer Manufacturing (9 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Zepp Health Corporation each representing sixteen (Class A) (ZEPP) ranks #624 by composite RQD confidence (35/100, grade D-) and #584 by equity capitalization ($33.0M). Within this direct 5-issuer industry benchmark cohort, OSS leads on earnings valuation at 28.6x trailing P/E, while OMCL leads on capital efficiency and profitability with 0.4% ROIC and 42.5% gross margin. OMCL currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with ZEPP at 35/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ZEPP ACTIVE Zepp Health Corporation each representing sixteen (Class A)	D-	35/100	—	38.3%	-14.7%	-3.85%	$33.0M	Benchmark Subject
OSS One Stop Systems Inc.	D	47/100	28.6x	49.6%	-18.0%	-6.88%	$145.7M	/oss-vs-zepp →
SCKT Socket Mobile Inc.	D-	40/100	—	49.7%	-35.0%	+5.94%	$3.0M	/sckt-vs-zepp →
XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares	D	49/100	—	—	—	-3.11%	$946.1M	/xndu-vs-zepp →
OMCL Omnicell Inc. ($0.001 par value)	C-	61/100	—	42.5%	0.4%	+2.59%	$1.68B	/omcl-vs-zepp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001720446

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Zepp Health Corporation each representing sixteen (Class A) (ZEPP) reported GAAP revenue of $258.9M (+41.8% vs. FY2024 revenue of $182.6M , and -26.6% cumulative change since FY2023) , GAAP net income of -$40.1M, operating cash flow of -$25.7M, and free cash flow of -$26.2M (-1.6% YoY). On the balance sheet, ZEPP closed FY2025 with $564.8M in total assets against $0 in total debt (Altman Z-Score: 0.33, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$258.9M	-$40.1M	-$25.7M	-$26.2M	$564.8M	—
FY2024 (FY)	2024-12-31	$182.6M	-$75.7M	-$24.4M	-$25.8M	$528.6M	—
FY2023 (FY)	2023-12-31	$352.9M	-$31.0M	$42.6M	$42.6M	—	—

3. ZEPP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ZEPP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.25 (-3.85% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #624 in composite RQD confidence.

How does ZEPP compare to OSS and SCKT in the Technology sector?

Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D grade (47/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ZEPP?

Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ZEPP trading relative to its 50-day, 200-day, and 52-week technical levels?

ZEPP last traded at $2.25 (-3.85% on volume of 68,747 shares), positioning the stock -43.18% below its 50-day simple moving average ($3.96) and -77.88% below its 200-day simple moving average ($10.17). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.2% percentile with a 14-day RSI of 11.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.97 to $2.53).

ZEPP Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is ZEPP's next earnings date?

Based on SEC filing cadence, Zepp Health Corporation each representing sixteen (Class A) (ZEPP)'s next quarterly reporting window is estimated around Dec 30, 2026.